HIV-1_NN
envelope_NN
glycoproteins_NNS
induce_VBP
activation_NN
of_IN
activated_VBN
protein-1_NN
in_IN
CD4_NN
+_CC
T_NN
cells_NNS
-LCB-_-LRB-
published_VBN
erratum_NN
appears_VBZ
in_IN
J_NNP
Biol_NNP
Chem_NNP
1995_CD
Dec_NNP
1_CD
;_:
270_CD
-LRB-_-LRB-
48_CD
-RRB-_-RRB-
:_:
29038_CD
-RCB-_-RRB-

Activation_NN
of_IN
CD4_NN
positive_JJ
T_NN
cells_NNS
is_VBZ
a_DT
primary_JJ
requirement_NN
for_IN
human_JJ
immunodeficiency_NN
virus_NN
-LRB-_-LRB-
HIV_NN
-RRB-_-RRB-
entry_NN
,_,
efficient_JJ
HIV_NN
replication_NN
,_,
and_CC
progression_NN
to_TO
AIDS_NN
,_,

Utilizing_VBG
CD4_NN
positive_JJ
T_NN
cell_NN
lines_NNS
and_CC
purified_VBN
T_NN
cells_NNS
from_IN
normal_JJ
individuals_NNS
,_,
we_PRP
have_VBP
demonstrated_VBN
that_IN
native_JJ
envelope_NN
glycoproteins_NNS
of_IN
HIV_NN
,_,
gp_NN
160_CD
,_,
can_MD
induce_VB
activation_NN
of_IN
transcription_NN
factor_NN
,_,
activated_VBN
protein-1_NN
-LRB-_-LRB-
AP-1_NN
-RRB-_-RRB-
._.

The_DT
stimulatory_JJ
effects_NNS
of_IN
gp160_NN
are_VBP
mediated_VBN
through_IN
the_DT
CD4_NN
molecule_NN
,_,
since_IN
treatment_NN
of_IN
gp160_NN
with_IN
soluble_JJ
CD4-IgG_NN
abrogates_VBZ
its_PRP$
activity_NN
,_,
and_CC
CD4_NN
negative_JJ
T_NN
cell_NN
lines_NNS
fail_VBP
to_TO
be_VB
stimulated_VBN
with_IN
gp160_NN
._.

Immunoprecipitation_NN
of_IN
the_DT
gp_NN
160-induced_JJ
nuclear_JJ
extracts_NNS
with_IN
polyclonal_JJ
antibodies_NNS
to_TO
Fos_NN
and_CC
Jun_NN
proteins_NNS
indicates_VBZ
that_IN
AP-1_NN
complex_NN
is_VBZ
comprised_VBN
of_IN
members_NNS
of_IN
these_DT
family_NN
of_IN
proteins_NNS
._.

The_DT
gp160-induced_JJ
AP-1_NN
complex_NN
is_VBZ
dependent_JJ
upon_IN
protein_NN
tyrosine_NN
phosphorylation_NN
and_CC
is_VBZ
protein_NN
synthesis-independent_JJ
._.

This_DT
stimulation_NN
can_MD
also_RB
be_VB
abolished_VBN
by_IN
inhibitors_NNS
of_IN
protein_NN
kinase_NN
C_NN
,_,
but_CC
it_PRP
is_VBZ
unaffected_JJ
by_IN
calcium_NN
channel_NN
blocker_NN
or_CC
cyclosporine_NN
A_NN
._.

This_DT
gp160_NN
treatment_NN
adversely_RB
affects_VBZ
the_DT
functional_JJ
capabilities_NNS
of_IN
T_NN
cells_NNS
:_:
pre-treatment_NN
of_IN
CD4_NN
+_CC
T_NN
cells_NNS
with_IN
gp160_NN
for_IN
4_CD
h_NN
at_IN
37_CD
degrees_NNS
C_NN
inhibited_VBD
anti-CD3-induced_JJ
interleukin-2_NN
secretion_NN
._.

Effects_NNS
similar_JJ
to_TO
gp160_NN
were_VBD
seen_VBN
with_IN
anti-CD4_JJ
mAb_NN
._.

The_DT
aberrant_JJ
activation_NN
of_IN
AP-1_NN
by_IN
gp160_NN
in_IN
CD4_NN
positive_JJ
T_NN
cells_NNS
could_MD
result_VB
in_IN
up-regulation_NN
of_IN
cytokines_NNS
containing_VBG
AP-1_NN
sites_NNS
,_,
e.g._FW
interleukin-3_NN
and_CC
granulocyte_NN
macrophage_NN
colony-stimulating_JJ
factor_NN
,_,
and_CC
concurrently_RB
lead_VB
to_TO
T_NN
cell_NN
unresponsiveness_NN
by_IN
inhibiting_VBG
interleukin-2_NN
secretion_NN
._.

